Lithium augmentation in antidepressant-resistant patients. A quantitative analysis

Austin, M.-P.V.; Souza, F.G.M.; Goodwin, G.M.; Austin, M P; Souza, F G
October 1991
British Journal of Psychiatry;Oct91, Vol. 159, p510
Academic Journal
journal article
A quantitative analysis was used to examine the efficacy of lithium augmentation in the acute treatment of depressed patients resistant to a standard trial of an antidepressant. Effect sizes were measured by the odds ratio using the Mantel-Haenszel method. Only controlled trials were included in order to minimise bias in method. A highly statistically significant effect for lithium augmentation was found, the pooled odds ratio being 0.146 and its 95% confidence interval 0.05-0.44 (i.e. the odds of remaining ill are reduced by between 56% and 95% with the use of lithium treatment). While these results support the case for lithium augmentation in treatment-resistant depression, there remains considerable uncertainty over the duration of treatment necessary to see and sustain the treatment response.


Related Articles

  • Lithium augmentation. Hodgkiss, A.D. // British Journal of Psychiatry;May95, Vol. 166, p679 

    A letter to the editor is presented in response to the article by Katona and colleagues in the January 1995 issue which described a well-designed study of lithium augmentation.

  • Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin. Nemeroff, Charles B.; Bissette, Garth; Akil, Huda; Fink, Max; Nemeroff, C B; Bissette, G; Akil, H; Fink, M // British Journal of Psychiatry;Jan91, Vol. 158, p59 

    The CSF concentrations of CRF, somatostatin and beta-endorphin were determined in nine patients who fulfilled DSM-III criteria for major depression with psychotic features. CSF samples were obtained at baseline in the depressed state, and again after a course of ECT. Concentrations of both CRF...

  • Schizophrenia, bipolar disorder and depression. A discriminant analysis, using 'lifetime' psychopathology ratings. Brockington, I.F.; Roper, A.; Copas, J.; Buckley, M.; Andrade, C.E.; Wigg, P.; Farmer, A.; Kaufman, C.; Hawley, R. // British Journal of Psychiatry;Oct91, Vol. 159, p485 

    Discriminant and canonical variate analyses were performed using 302 patients, on whom ratings of lifetime psychopathology and course of illness has been made. DSM-III diagnoses were used to form the criterion groups. Bipolar disorder emerged as a distinct grouping, but there are reasons for...

  • Re: A time to bury tricyclic antidepressants or to praise them? Berber, Mark J.; Berber, M J // Canadian Journal of Psychiatry;Aug1997 Supplement, Vol. 42 Issue 6, p663 

    A letter to the editor is presented in response to the article "A Time to Bury Tricyclic Antidepressants or to Praise Them?" in the previous issue.

  • Prediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology of depression. Hickie, Ian; Parsonage, Brian; Parker, Gordon; Hickie, I; Parsonage, B; Parker, G // British Journal of Psychiatry;Jul90, Vol. 157, p65 

    In an open study of 35 depressed patients, psychomotor disturbance, assessed by the CORE rating system, significantly predicted response to ECT in patients with a 'retarded' but not those with an 'agitated' type of illness. In multivariate analyses, psychomotor disturbance was the sole predictor...

  • Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood. Burns, Alistair; Jacoby, Robin; Levy, Raymond; Burns, A; Jacoby, R; Levy, R // British Journal of Psychiatry;Jul90, Vol. 157, p81 

    Of 178 patients with AD, at least one depressive symptom was reported by 63%, 24% were rated as being depressed by a trained observer, and 43% were considered depressed by their relatives. Ten per cent had a previous history of depression. Elevated mood was rare, occurring in only six patients...

  • A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Kennedy, Sidney H.; Javanmard, Mahan; Vaccarino, Franco J.; Kennedy, S H; Javanmard, M; Vaccarino, F J // Canadian Journal of Psychiatry;Jun1997, Vol. 42 Issue 5, p467 

    Objective: To examine the progress of positron emission tomography (PET) as a tool for understanding the psychobiology of mood disorders, particularly major depression and bipolar disorder. Method: Review of the literature on functional imaging of mood disorders....

  • Differentiating DSM-IV anxiety and depressive disorders in the general population: comorbidity and treatment consequences. Ohayon, Maurice M; Shapiro, Colin M; Psych, MRC; Kennedy, Sidney H; Ohayon, M M; Shapiro, C M; Kennedy, S H // Canadian Journal of Psychiatry;Mar2000, Vol. 45 Issue 2, p166 

    Objective: To attempt, for the first time, to apply a positive and differential diagnosis process in the general population during interviews using DSM-IV classification to ascertain the profile and occurrence of concomitant mental disorders.Method: A representative...

  • Lithium augmentation in antidepressant-resistant patients. Flint, Alastair; Flint, A // British Journal of Psychiatry;May92, Vol. 160, p710 

    A letter to the editor is presented commenting on an article in the October 1991 issue on lithium augmentation in depressed patients who are resistant to antidepressants.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics